E25.8
Other adrenogenital disorders
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Inclusion Terms
- Idiopathic adrenogenital disorder
Medical Intelligence & Overview
Other adrenogenital disorders, classified under ICD-10 code E25.8, encompass a variety of rare conditions affecting the adrenal glands and their influence on development of sexual characteristics. These disorders are often referred to as idiopathic adrenogenital disorders, indicating that their exact cause is unknown. They primarily impact hormone production, leading to a range of physical and developmental effects that can vary among individuals. Recognizing the signs and understanding the nature of these disorders is essential for proper management and care.
Causes & Symptoms
Clinical Causes: Genetic factors that influence the adrenal glands Unknown or idiopathic factors, as the specific cause often remains unidentified Possible minor hormonal imbalances affecting adrenal hormone secretion Environmental influences or exposures that may impact adrenal function, though less common
Key Symptoms: Abnormal development of sexual characteristics before birth or during adolescence Overproduction of adrenal hormones such as androgens, leading to virilization in females or precocious puberty in both sexes Ambiguous genitalia in newborns, presenting as atypical external genitalia Enlargement of the clitoris in females or early development of facial hair in males Rapid growth during childhood but early closure of growth plates, resulting in shorter adult stature Skeletal abnormalities, such as increased bone age or early epiphyseal closure Hormonal imbalances detectable through laboratory testing, including elevated androgen levels
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination, hormonal testing, and imaging studies. Physicians typically assess hormonal levels, including androgens, cortisol, and other adrenal hormones, to identify abnormalities. Imaging techniques like ultrasound or MRI may be used to examine adrenal gland structure or detect tumors, if suspected. Genetic counseling and testing can also assist in understanding underlying factors. Since the exact cause often remains unknown, diagnosis primarily focuses on identifying the hormonal and physical manifestations.
Treatment Protocols: Hormonal therapy to regulate androgen levels and develop typical secondary sexual characteristics Surgical intervention in cases of ambiguous genitalia or to correct anatomical anomalies Regular monitoring of hormone levels and physical development to adjust treatments accordingly Supportive therapies such as counseling or psychological support, especially if there are concerns related to physical appearance or development
Clinical Advice & FAQs
Billing Guidance
Is E25.8 a billable ICD-10 code?
Yes, E25.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E25.8?
Clinical documentation must specify the nature of Other adrenogenital disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference